A Pennsylvania jury delivered a $175 million verdict against Monsanto (now owned by Bayer) in March 2024, finding the company liable for failing to warn consumers about cancer risks associated with its Roundup herbicide. The verdict represents one of the largest single-plaintiff awards in Roundup litigation and reflects a Pennsylvania jury’s determination that adequate warnings about glyphosate—Roundup’s active ingredient—were missing from the product despite internal knowledge of potential cancer links.
This case adds to the growing body of jury decisions holding Monsanto accountable for what plaintiffs’ attorneys argue was a decades-long failure to communicate risks that the company may have known about. The $175 million award consisted of both compensatory damages for the plaintiff’s injuries and suffering, as well as punitive damages designed to hold Monsanto accountable for its conduct. This verdict demonstrates that juries continue to find merit in cases where plaintiffs can show they were exposed to Roundup without adequate warnings, contracted non-Hodgkin’s lymphoma or other cancers, and that the company’s marketing practices contributed to that exposure.
Table of Contents
- What Was the Pennsylvania $175 Million Roundup Cancer Verdict About?
- How Does the $175 Million Award Compare to Other Roundup Verdicts?
- What Role Did Internal Documents Play in This Verdict?
- What Does This Verdict Mean for People Who Used Roundup?
- What Are the Limitations and Risks in Relying on This Verdict?
- How Have Other States and Courts Handled Roundup Cases?
- What Is the Current Status of Roundup Litigation?
What Was the Pennsylvania $175 Million Roundup Cancer Verdict About?
The Pennsylvania case centered on a plaintiff who alleged that regular exposure to Roundup herbicide led to the development of cancer. monsanto‘s internal documents, disclosed during litigation, became a focal point—many showed discussions about glyphosate’s potential health effects dating back decades, yet the company maintained its product was safe when used as directed. The jury in this case weighed evidence about the plaintiff’s exposure history, medical condition, and whether Monsanto had adequately communicated known risks. The verdict specifically addressed the question of whether Monsanto should have included stronger warnings on Roundup labels and in marketing materials about the potential cancer risk.
Unlike some settlements that occur without any admission of wrongdoing, jury verdicts represent a formal finding that a company failed in its duty to warn consumers. The scale of the award—particularly the punitive damages component—signaled the jury’s view that this was not merely a product defect case, but one involving corporate negligence or misconduct. This case is notable because Pennsylvania is a significant agricultural state where Roundup use has been widespread among both commercial farmers and homeowners. The verdict outcome may influence how other Pennsylvania residents who used Roundup and developed cancer view their own legal options.
How Does the $175 Million Award Compare to Other Roundup Verdicts?
The Roundup litigation landscape has produced numerous verdicts over the past several years, with amounts varying significantly based on individual circumstances. Earlier california verdicts against Monsanto ranged from $289 million (Hardeman v. Monsanto) down to lower amounts in some cases. The Pennsylvania $175 million verdict falls within the range of major awards but reflects the specific damages and jury composition of that particular trial. It’s important to note that many Roundup cases have also resulted in defense verdicts, where juries found in Monsanto’s favor.
One critical limitation to understand: jury verdicts are not final judgments and are often appealed. The Pennsylvania verdict will likely face appeal challenges from Bayer, during which lawyers will argue the evidence was insufficient or the damages excessive. Appeals can take years to resolve, and verdicts may be reduced, upheld, or overturned on technical grounds. If you’re tracking how this case might affect your own potential claim, recognize that the path from verdict to final judgment is complex and uncertain. Many Roundup verdicts have also been subject to post-trial motions where judges reduced damages amounts they deemed excessive under state law. The actual amount paid—if any—may differ substantially from the initial jury award.
What Role Did Internal Documents Play in This Verdict?
Monsanto’s internal emails, memos, and research communications proved crucial in the Pennsylvania case, much as they have in other Roundup litigation. Documents suggesting the company discussed potential carcinogenic effects of glyphosate but chose not to incorporate those concerns into consumer-facing warnings became powerful evidence for the plaintiff’s legal team. For example, internal discussions about safety studies and how to handle certain research findings can suggest the company knew or should have known about risks. These documents don’t necessarily prove Monsanto acted with definite knowledge that Roundup caused cancer—the scientific question remains genuinely debated.
What they do show is that the company was aware of concerns and questions about safety that, according to the plaintiff’s argument, should have been disclosed to consumers in clearer terms. The jury in Pennsylvania apparently agreed that the absence of adequate warnings, in light of what the company apparently knew or suspected, constituted negligence. Access to internal documents occurs through a legal process called discovery, where both sides exchange relevant evidence before trial. In the Roundup cases, several major documents became repeatedly used across multiple trials because they suggest a pattern of knowledge and communication gaps.
What Does This Verdict Mean for People Who Used Roundup?
If you used Roundup as a homeowner, farmer, or landscape professional and were subsequently diagnosed with cancer, this Pennsylvania verdict may bolster the legal case that you have a claim. It shows that at least one jury found Monsanto’s failure to warn compelling enough to hold the company financially accountable. However, the existence of this verdict does not guarantee success in your own case—each trial outcome depends on specific facts, the judge, the jury, and local law.
An important tradeoff to understand: pursuing your own case means investing time and potentially money in legal fees, medical documentation, and expert testimony. Class action settlements, by contrast, are typically easier to enter and require less involvement, though individual payouts in settlements are generally smaller than what a jury verdict might award. Some Roundup cases have been consolidated into multi-district litigation (MDL), which centralizes discovery and pretrial matters but may still result in individual trials or negotiated settlements. The stronger practical point: if you have a documented cancer diagnosis you believe is connected to Roundup exposure, the existence of verdicts like this Pennsylvania one means that attorneys specializing in toxic tort litigation are likely willing to evaluate your claim at no upfront cost.
What Are the Limitations and Risks in Relying on This Verdict?
One significant limitation is that the scientific evidence linking glyphosate to cancer remains contested in the broader medical and scientific communities. The International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic,” but other regulatory bodies, including the EPA, have concluded that glyphosate is not likely to be carcinogenic. Jury verdicts are not scientific determinations—they reflect what a group of laypersons decided based on evidence and arguments presented in that specific case. A different jury, in a different jurisdiction, with different expert witnesses, might reach a different conclusion. Additionally, appeals courts sometimes overturn large verdicts based on the argument that the damages were excessive relative to similar cases or that the evidence was legally insufficient to support the verdict.
There’s also the risk that Bayer—which acquired Monsanto in 2018—might not have sufficient assets to pay large verdicts, though Bayer is a major pharmaceutical company with substantial resources. Nevertheless, bankruptcy or negotiated settlement reduction remains a possibility in major litigation. A warning for those considering filing a claim: statutes of limitations apply in every state, meaning there is a deadline to file your lawsuit. These deadlines typically run from the time of diagnosis, not from the time of exposure, but they vary by state. If you believe you have a claim, consulting with an attorney sooner rather than later is prudent.
How Have Other States and Courts Handled Roundup Cases?
Beyond Pennsylvania, Roundup litigation has unfolded across multiple state court systems and federal court (through the MDL process). California courts have been particularly active venues, as has federal court in the Northern District of California. State-by-state differences in product liability law, procedural rules, and jury composition mean that outcomes vary.
Some courts have been more receptive to plaintiffs’ arguments, while others have been more protective of defendant rights. For example, a homeowner in one state might have a stronger legal path to recovery than someone in another state, simply due to differences in how that state defines a manufacturer’s duty to warn. This geographic variation means that where your exposure and diagnosis occurred may influence both your likelihood of success and the potential award amount.
What Is the Current Status of Roundup Litigation?
As of 2024, the Roundup litigation remains active, with new cases still being filed and existing cases working through various stages of litigation and appeals. Bayer has faced pressure to resolve outstanding claims, and several settlement discussions have occurred, though a comprehensive global settlement resolving all pending Roundup litigation has not materialized in the way that some observers anticipated. The Pennsylvania verdict is part of an ongoing pattern of jury decisions that keep pressure on the defendant.
Looking forward, the outcome of appellate decisions in major cases will likely shape the trajectory of remaining Roundup litigation. If verdicts are upheld, it strengthens the position of other plaintiffs and may increase settlement pressure. If they are significantly reduced or overturned on appeal, it could shift the landscape. Regardless, the sheer volume of claims and the persistence of jury verdicts suggest that Roundup litigation will continue as a significant area of toxic tort law for years to come.
You Might Also Like
- Monsanto Roundup $332 Million California Cancer Verdict
- Monsanto Roundup $2.25 Billion Consolidated Cancer Verdict
- Monsanto Roundup $2.1 Billion Georgia Cancer Verdict
Open Settlements You Can Claim Now
Browse current class action settlements accepting claims — several require no proof of purchase: